Small Pharmaceuticals
Market Cap
₹3,012 ₹3,012 Cr.
P/E
83.56
PEG
9.18
PEG = P/E ÷ 5yr forward EPS CAGR
5yr forward EPS CAGR thesis · Base case

The thesis becomes credible if the FY26 revenue base proves repeatable and FY27 consolidated revenue remains on the modeled path, with Q2 FY27 providing the near-term validation point.

The bull case depends on MedTech commercialization and stronger export conversion, while the bear case reflects failed revenue repeatability, weak exports, and margin pressure.

Financial

Business

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material